Published Date: 24 Apr 2023
Canada: The Journal of Psychiatric Research recently reported that childhood cat ownership, particularly with rodent-hunting cats,.
Read Full NewsEven years after treatment ends, adjuvant osimertinib brings an overall survival benefit to patients with resected EGFR-mutated lung cancer.
In patients with newly diagnosed stage IVB cervical cancer, adding definitive-dose pelvic radiotherapy to chemotherapy was associated with longer survival compared with chemotherapy alone.
Two B7-H3-directed antibody-drug conjugates substantially improve survival over topotecan among patients with relapsed small cell lung cancer — pointing to a potential new treatment class.
Two analyses of liso-cel CAR T-cell therapy in relapsed or refractory mantle cell lymphoma show response rates in the real-world setting similar to those seen in clinical trial populations.
Antibiotic use in patients under hospice care is associated with an increased risk for mortality; for infectious hospice-qualifying conditions, antibiotic use is linked to extended survival.
1.
Can 80 Gy Radiation Boost Survival in Prostate Cancer?
2.
Vepdegestrant Earns FDA Nod for ESR1-Mutated Breast Cancer
3.
FDA Panel Endorses Capivasertib Use in Prostate Cancer
4.
Small-Town Patients Face Big Hurdles as Rural Hospitals Cut Cancer Care
5.
novel technique for early myelodysplastic syndrome relapse detection in blood cancer patients.
1.
Progressive Changes in Tumor Tissue Fluid Transport and Interstitial Pressure: Mechanisms, Clinical Implications, and Therapeutic Advances
2.
Mastering Modern Oncology: Accreditation, Education, and Research Trends for 2025
3.
Colon cancer: Risk factors, warning signs and treatment options
4.
Targeting Oncology: Expanding Combinatorial Strategies by 2025
5.
Integrated Techniques in Oncology in the Digital Era
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part V
2.
From Relapse to Remission: Mapping the Treatment Journey in Adult R/R-Cell ALL - Part 2
3.
An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion IV
4.
How Platelet Disorders Can Affect the Body
5.
The Era of Targeted Therapies for ALK+ NSCLC: A Paradigm Shift
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation